Cibus (CBUS) Treasury Shares (2017 - 2026)
Cibus (CBUS) posted Treasury Shares of $2.1 million for Q4 2025, up 3.43% sequentially from $2.1 million in Q3 2025, and up 7.1% YoY from $2.0 million in Q4 2024.
Cibus (CBUS) Treasury Shares (2017 - 2026) Analysis & Trends
Cibus has reported Treasury Shares for 8 years, with the latest figure at $2.1 million in Q4 2025.
- Quarterly Treasury Shares rose 7.1% year-over-year to $2.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.1 million (up 7.1% YoY) and the FY2025 annual result came in at $2.1 million, up 7.1% from the prior year.
- Treasury Shares grew to $2.1 million in Q4 2025 per CBUS's latest filing, from $2.1 million in the prior quarter.
- Over five years, Treasury Shares peaked at $7.8 million in Q1 2022 and troughed at $22600.0 in Q4 2022.
- A 5-year average of $1.3 million and a median of $522557.5 in 2021 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2021 and 2024: Treasury Shares changed 0.0% in 2021, then jumped 83.32% in 2024.
- Over 5 years, Treasury Shares stood at $1.0 million in 2021, then changed by 0.0% to $1.0 million in 2022, then soared by 71.14% to $1.8 million in 2023, then climbed by 11.99% to $2.0 million in 2024, then increased by 7.1% to $2.1 million in 2025.
- According to Business Quant data, Treasury Shares over the past three periods registered $2.1 million, $2.1 million, and $2.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 2.72 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 8.96 Mn |
| 10 | Cibus | 131.25 Mn | 110.82 Mn | - | 2.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.83 Mn |
| Jun 30, 2026 | 2.83 Mn |
| Jun 30, 2026 | 2.26 Mn |
| Jun 30, 2026 | 2.26 Mn |
| Dec 31, 2025 | 193,195.00 |
| Dec 31, 2025 | 193,195.00 |
| Dec 31, 2025 | 2.14 Mn |
| Dec 31, 2025 | 2.14 Mn |
| Sep 30, 2025 | 1.57 Mn |
| Sep 30, 2025 | 1.57 Mn |
| Sep 30, 2025 | 2.07 Mn |
| Sep 30, 2025 | 2.07 Mn |
| Jun 30, 2025 | 2.04 Mn |
| Jun 30, 2025 | 153,490.00 |
| Jun 30, 2025 | 153,490.00 |
| Jun 30, 2025 | 2.04 Mn |
| Mar 31, 2025 | 192,288.00 |
| Mar 31, 2025 | 2.01 Mn |
| Mar 31, 2025 | 2.01 Mn |
| Mar 31, 2025 | 192,288.00 |